Neogen Financials

NEOG Stock  USD 4.78  0.05  1.06%   
Based on the analysis of Neogen's profitability, liquidity, and operating efficiency, Neogen is performing exceptionally good at this time. It has a great probability to report excellent financial results in August. At this time, Neogen's Other Current Liabilities is most likely to increase significantly in the upcoming years. The Neogen's current Total Current Liabilities is estimated to increase to about 186.3 M, while Short Term Investments are projected to decrease to roughly 355.1 K. Key indicators impacting Neogen's financial strength include:
Operating Margin
0.0245
Profit Margin
(0.54)
Short Ratio
4.79
EPS Estimate Current Year
0.36
EPS Estimate Current Quarter
0.115
The essential information of the day-to-day investment outlook for Neogen includes many different criteria found on its balance sheet. An individual investor should monitor Neogen's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Neogen.

Net Income

(10.29 Million)

  
Build AI portfolio with Neogen Stock

Neogen Stock Summary

Neogen competes with Cigna Corp, Definitive Healthcare, Edwards Lifesciences, Guardant Health, and Laboratory. Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan. Neogen Cp operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 2108 people.
Specialization
Health Care, Health Care Equipment & Services
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS6404911066
CUSIP640491106
LocationMichigan; U.S.A
Business Address620 Lesher Place,
SectorHealth Care Equipment & Supplies
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.neogen.com
Phone(517) 372 9200
CurrencyUSD - US Dollar

Neogen Key Financial Ratios

Neogen Key Balance Sheet Accounts

202020212022202320242025 (projected)
Total Assets920.2M992.9M4.6B4.5B5.2B5.5B
Other Current Liab26.6M35.6M57.2M48.6M55.9M58.7M
Net Debt(379.8M)605.6M736.8M735.6M846.0M888.3M
Retained Earnings539.6M587.9M565.0M555.6M639.0M670.9M
Cash381.1M381.1M163.2M170.6M196.2M206.0M
Net Receivables91.8M99.7M153.3M173.0M199.0M208.9M
Inventory100.7M122.3M133.8M189.3M217.7M228.5M
Other Current Assets35.7M47.5M53.3M56.0M64.4M67.7M
Total Liab79.8M105.6M1.4B1.4B1.6B1.7B
Total Current Assets591.5M626.8M585.9M589.2M677.6M711.5M
Short Term Debt1.3M1.4M3.3M7.5M8.7M9.1M
Intangible Assets92.3M107.5M1.6B1.5B1.7B1.8B
Accounts Payable23.9M34.6M76.7M83.1M95.5M100.3M
Common Stock17.2M17.2M34.6M34.7M39.9M37.9M
Other Liab22.6M26.2M27.7M375.7M432.1M453.7M
Other Assets2.0M4.8B15.2M1.01.151.09
Good Will228.3M255.5M3.8B2.1B2.5B2.6B
Net Tangible Assets599.6M612.1M887.4M3.1B3.6B3.8B

Neogen Key Income Statement Accounts

202020212022202320242025 (projected)
Interest Expense78K1.3M56.0M73.4M84.4M88.6M
Total Revenue468.5M527.2M822.4M924.2M1.1B1.1B
Gross Profit215.1M243.0M406.0M463.9M533.5M560.2M
Operating Income53.1M34.9M37.5M58.7M67.5M70.8M
Ebit77.3M84.2M37.5M61.4M70.6M74.1M
Ebitda98.3M107.9M125.9M182.6M210.0M220.5M
Cost Of Revenue253.4M284.1M416.5M460.3M529.4M555.8M
Income Before Tax75.3M60.2M(22.0M)(14.3M)(16.5M)(15.6M)
Net Income60.9M48.3M(22.9M)(9.4M)(10.8M)(10.3M)
Income Tax Expense14.4M11.9M828K(4.9M)(5.6M)(5.3M)
Research Development16.2M17.0M26.0M22.5M25.8M27.1M
Tax Provision14.4M11.9M828K(4.9M)(4.4M)(4.2M)
Interest Income1.6M1.3M3.2M6.4M7.3M7.7M
Net Interest Income1.6M1.3M(52.8M)(67.0M)(60.3M)(57.3M)

Neogen Key Cash Accounts

202020212022202320242025 (projected)
Change To Inventory2.5M(21.1M)10.0M(55.9M)(50.4M)(47.8M)
Free Cash Flow54.4M43.6M(24.7M)(76.2M)(87.6M)(83.2M)
Depreciation21.0M23.7M88.4M121.2M139.4M146.4M
Other Non Cash Items51.9M73.2M7.4M9.8M11.3M11.8M
Capital Expenditures26.7M24.4M65.8M111.4M128.1M134.5M
Net Income60.9M48.3M(22.9M)(9.4M)(10.8M)(10.3M)
End Period Cash Flow75.6M44.5M163.2M170.6M196.2M206.0M
Change In Cash9.3M(31.1M)118.8M7.4M8.5M6.2M
Investments(28.1M)(34.1M)254.2M(29.3M)(33.7M)(32.0M)
Change Receivables(2.9M)(2.6M)(7.8M)(53.9M)(48.5M)(46.1M)
Change To Netincome8.1M5.8M2.5M(6.4M)(7.4M)(7.0M)

Neogen Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Neogen's current stock value. Our valuation model uses many indicators to compare Neogen value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Neogen competition to find correlations between indicators driving Neogen's intrinsic value. More Info.
Neogen is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Neogen by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Neogen Systematic Risk

Neogen's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Neogen volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Neogen correlated with the market. If Beta is less than 0 Neogen generally moves in the opposite direction as compared to the market. If Neogen Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Neogen is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Neogen is generally in the same direction as the market. If Beta > 1 Neogen moves generally in the same direction as, but more than the movement of the benchmark.

Neogen Thematic Clasifications

Neogen is part of Health Management investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Healthcare providers, hospitals. Major hospitals and healthcare providers
Health ManagementView
This theme covers Healthcare providers, hospitals. Major hospitals and healthcare providers. Get More Thematic Ideas

Neogen July 2, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Neogen help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Neogen. We use our internally-developed statistical techniques to arrive at the intrinsic value of Neogen based on widely used predictive technical indicators. In general, we focus on analyzing Neogen Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Neogen's daily price indicators and compare them against related drivers.

Complementary Tools for Neogen Stock analysis

When running Neogen's price analysis, check to measure Neogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neogen is operating at the current time. Most of Neogen's value examination focuses on studying past and present price action to predict the probability of Neogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neogen's price. Additionally, you may evaluate how the addition of Neogen to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Equity Valuation
Check real value of public entities based on technical and fundamental data
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes